Commonwealth Equity Services
NAVB

Commonwealth Equity Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Commonwealth Equity Services’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-51,203
Closed -$51K – 3852
2021
Q4 		$51K Buy
+51,203
New +$72.1K ﹤0.01% 3530
2019
Q2 		– Sell
-1,539
Closed -$4K – 2856
2019
Q1 		$4K Hold
1,539
– – ﹤0.01% 2740
2018
Q4 		$3K Hold
1,539
– – ﹤0.01% 2673
2018
Q3 		$7K Hold
1,539
– – ﹤0.01% 2779
2018
Q2 		$7K Hold
1,539
– – ﹤0.01% 2755
2018
Q1 		$11K Buy
1,539
+10
+0.7% +$75 ﹤0.01% 2694
2017
Q4 		$11K Hold
1,529
– – ﹤0.01% 2662
2017
Q3 		$13K Sell
1,529
-75
-5% -$636 ﹤0.01% 2544
2017
Q2 		$16K Sell
1,604
-100
-6% -$989 ﹤0.01% 2493
2017
Q1 		$20K Hold
1,704
– – ﹤0.01% 2387
2016
Q4 		$22K Hold
1,704
– – ﹤0.01% 2287
2016
Q3 		$31K Hold
1,704
– – ﹤0.01% 2192
2016
Q2 		$18K Sell
1,704
-36
-2% -$707 ﹤0.01% 2207
2016
Q1 		$33K Hold
1,740
– – ﹤0.01% 2152
2015
Q4 		$46K Sell
1,740
-50
-3% -$1.74K ﹤0.01% 2109
2015
Q3 		$82K Sell
1,790
-100
-5% -$3.77K ﹤0.01% 2008
2015
Q2 		$61K Hold
1,890
– – ﹤0.01% 2120
2015
Q1 		$60K Hold
1,890
– – ﹤0.01% 2107
2014
Q4 		$71K Sell
1,890
-100
-5% -$2.75K ﹤0.01% 2004
2014
Q3 		$53K Sell
1,990
-101
-5% -$2.67K ﹤0.01% 2011
2014
Q2 		$62K Buy
2,091
+86
+4% +$2.78K ﹤0.01% 1975
2014
Q1 		$74K Buy
2,005
+75
+4% +$2.85K ﹤0.01% 1910
2013
Q4 		$80K Buy
1,930
+186
+11% +$7.28K ﹤0.01% 1838
2013
Q3 		$92K Buy
1,744
+100
+6% +$5.83K ﹤0.01% 1763
2013
Q2 		$88K Buy
+1,644
New +$82.1K ﹤0.01% 1700

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Commonwealth Equity Services's NAVB Position: Q1 2022 in Review

Commonwealth Equity Services sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2022, closing a stake of 51,203 shares — an estimated $51K sold.

Commonwealth Equity Services first reported a position in NAVB in Q2 2013 and held it in 25 quarters. The position peaked at $92K in Q3 2013. 25 funds tracked by Wall St. Rank hold NAVB as of Q1 2022.

  • Commonwealth Equity Services reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 51,203 Navidea Biopharmaceuticals Inc. shares in Q1 2022, an estimated $51K.
  • Commonwealth Equity Services first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 25 quarters.
  • Commonwealth Equity Services's Navidea Biopharmaceuticals Inc. position peaked at $92K in Q3 2013.
  • 25 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2022.

Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.